Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Imatinib in Elderly Ph+ CML Patients
NCT00858806Phase 2Completed
- Sponsor
- University of Brescia
- Start
- Apr 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in chronic myeloid leukemia (CML), sponsored by University of Brescia. Primary endpoint: Proportion of patients maintaining Complete Cytogenetic Response at 1 year. Started Apr 2008; status: completed.
02
Drugs
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00858806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00858806.